🇺🇸 raloxifen in United States

22 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Cough — 3 reports (13.64%)
  2. Pneumonia — 3 reports (13.64%)
  3. Asthma — 2 reports (9.09%)
  4. Bradycardia — 2 reports (9.09%)
  5. Dizziness — 2 reports (9.09%)
  6. Dyspnoea — 2 reports (9.09%)
  7. Headache — 2 reports (9.09%)
  8. Muscle Spasms — 2 reports (9.09%)
  9. Myocardial Infarction — 2 reports (9.09%)
  10. Nausea — 2 reports (9.09%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is raloxifen approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for raloxifen in United States?

Organon and Co is the originator. The local marketing authorisation holder may differ — check the official source linked above.